Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
Increased risk for NAION seen among participants with T2D, overweight/obesity receiving semaglutide versus non-GLP1-RA meds
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.